Cargando…
Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169916/ https://www.ncbi.nlm.nih.gov/pubmed/36929063 http://dx.doi.org/10.3988/jcn.2022.0468 |
_version_ | 1785039141571919872 |
---|---|
author | Kang, Kyusik Lee, Jung-Ju Kim, Byung-Kun |
author_facet | Kang, Kyusik Lee, Jung-Ju Kim, Byung-Kun |
author_sort | Kang, Kyusik |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10169916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Korean Neurological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-101699162023-05-11 Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond Kang, Kyusik Lee, Jung-Ju Kim, Byung-Kun J Clin Neurol Letter to the Editor Korean Neurological Association 2023-05 2023-03-13 /pmc/articles/PMC10169916/ /pubmed/36929063 http://dx.doi.org/10.3988/jcn.2022.0468 Text en Copyright © 2023 Korean Neurological Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Kang, Kyusik Lee, Jung-Ju Kim, Byung-Kun Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond |
title | Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond |
title_full | Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond |
title_fullStr | Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond |
title_full_unstemmed | Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond |
title_short | Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond |
title_sort | re: comments on “recurrent aseptic meningoencephalitis following bnt162b2 vaccination for covid-19”: the authors respond |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169916/ https://www.ncbi.nlm.nih.gov/pubmed/36929063 http://dx.doi.org/10.3988/jcn.2022.0468 |
work_keys_str_mv | AT kangkyusik recommentsonrecurrentasepticmeningoencephalitisfollowingbnt162b2vaccinationforcovid19theauthorsrespond AT leejungju recommentsonrecurrentasepticmeningoencephalitisfollowingbnt162b2vaccinationforcovid19theauthorsrespond AT kimbyungkun recommentsonrecurrentasepticmeningoencephalitisfollowingbnt162b2vaccinationforcovid19theauthorsrespond |